12 August 2024 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice on two medicines.

Etranacogene dezaparvovec (Hemgenix) was accepted on an interim basis for the treatment of adults with haemophilia B, an inherited bleeding disorder. The medicine will be available while further evidence is gathered. Following this, SMC will review the evidence and decide on routine availability in NHSScotland.

Read SMC press release